At the heart of the pharmaceutical industry lies a paradox: Devoted to helping people get well, the drug industry depends on patients staying sick. Clayton Dalton, a resident at the Massachusetts General Hospital in Boston, traces the economic forces that influence research and treatment choices for chronic disease. For anyone interested in the business of health and disease, getAbstract recommends Dalton’s analysis of the interactions of money and medicine.
In this summary, you will learn
How economic incentives distort medical research and treatment,
How the paradigm for pharmaceutical production emerged, and
How some organizations are supporting research and treatment apart from economic incentives.
About the Author
Clayton Dalton is a medical resident at the Massachusetts General Hospital in Boston.